SynthesisF1000Research2021

Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trials.

Bendix Samarta Witarto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.